
Caixa joins CRB in €3m round for Nuubo
Caixa Capital Risc and CRB Inverbio have committed €3m to wearable medical technology company Nuubo.
Caixa invested via Caixa Innvierte BioMed II, which launched in March 2014 with a €35m target. CRB committed capital from CRB Bio II.
Fides Capital, an existing backer, remains the lead investor in the company alongside new minority partners.
The company expects to grow its revenues in Europe with the aim of exceeding €1m of sales in 2014.
Company
Founded in 2012 and based in Madrid, Nuubo has developed biomedical garments for heart monitoring. The firm's technology allows the electrocardiogram to be read continuously in a non-invasive manner via a piece of clothing. Data can be sent wirelessly and in real time. The firm has also developed analysis and visualisation using artificial intelligence algorithms.
Nuubo employs 22 staff.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater